Skip to content

Agammaglobulinemia 5 Autosomal Dominant C3150753

Published: July 22, 2026Updated: August 20, 2026

A rare primary immunodeficiency with severely low or absent antibodies due to impaired B cell development. Both males and females can be affected. Treatment involves lifelong immunoglobulin replacement and infection prevention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent pneumonia

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent otitis media

(otorhinolaryngologic)

Persistent gastrointestinal infection

(gastrointestinal)

Severe skin abscess

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immunoglobulin Replacement Therapy

Immunoglobulin replacement therapy remains the primary treatment regardless of inheritance pattern. Dosing is individualized based on body weight and IgG trough levels to maintain adequate protection.

medication
3

Targeted Antibiotic Therapy

Aggressive antibiotic treatment at first sign of infection with broad-spectrum coverage initially, then culture-directed therapy. Consider prophylactic antibiotics during high-risk periods.

medication

Additional treatment options

Vaccination Guidance and Avoidance Protocol

Administration of inactivated vaccines per standard schedules; strict avoidance of all live attenuated vaccines including MMR, varicella, and oral polio. Family members should also avoid oral polio vaccine.

procedure

Probiotic Supplementation

Probiotic supplementation to support gut-associated lymphoid tissue and maintain healthy microbiome, which plays a role in immune function. Choose strains appropriate for immunodeficiency patients.

complementary

Disease Complication Surveillance

Regular monitoring for complications including bronchiectasis, chronic lung disease, autoimmune manifestations, and lymphoproliferative disorders that can occur despite immunoglobulin therapy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Agammaglobulinemia 5 Autosomal Dominant C3150753?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Conley ME, Rohrer J, Minegishi Y. X-linked and autosomal recessive agammaglobulinemia: a spectrum of immune defects. Curr Opin Immunol. 2022.

review2022
2

Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2022.

guideline2022
3

Chapel H, Cunningham-Rundles C. Molecular characterization of autosomal dominant agammaglobulinemia in clinical cohorts. Clin Immunol. 2021.

clinical_trial2021
4

Elashi AA, Al-Herz W, Segal F, et al. Immunoglobulin replacement therapy outcomes in primary agammaglobulinemia: a systematic review and meta-analysis. J Clin Immunol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Agammaglobulinemia 5 Autosomal Dominant C3150753. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy